BANGALORE, May 31, 2018 /PRNewswire/ --
The Contextual Learning program at Canadian International School strivesto take students out of their comfort zones and put them in new contexts where they come face-to-face with issues, people, and places they don't normally cross paths with. This philosophy led to a partnership between Canadian International School and
(Logo: https://mma.prnewswire.com/media/638328/CIS_Logo.jpg )
31st May is celebrated around the globe as the World Against Tobacco Day. This is a perfect opportunity for students to be global citizens and contribute their opinions and thoughts on the matter. They are going to do so through their sculpture, art, and theatre arts.
Join the students from Canadian International School along with Cytecare Cancer Hospitals on 31st May 2018 at the Rangoli Art Centre on 1MG road, Bangalore from 10 am to 1 pm.
About Canadian International School
Canadian International School is a culturally-rich mosaic serving each student by providing a world-class international education, nurturing potential, developing life-long skills, and preparing students for an ever-changing global community. As India's 1st Apple Distinguished School, Canadian International School has continued to deliver a very high standard of education with an array of subject choices and activities tailored to students' interests, aligned with a very high level of care in a warm, friendly and non- threatening environment. It follows internationally recognized curricula - IB (Grades 11-12), IGCSE (Grades 9-10), Cambridge Secondary 1 (Grades 6-8) Cambridge Primary, and Montessori (Pre K-Grade 5), and employs a majority of foreign-trained, experienced teachers.
Media Contact: Amala Warrick email@example.com +91-9008607755 Canadian International School
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All